Edgar Wachenheim III
Greenhaven Associates
Edgar Wachenheim III Baxter International Inc stake
total: 102
Greenhaven Associates BAX trades
- Total transactions:
- 4
- New positions:
- 1
- Added:
- 2
- Reduced:
- 1
- Held since:
- 2025 Q3
- Held for:
- 4 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Edgar Wachenheim III holds 14,285,228 Baxter International Inc (BAX) shares with a market value of roughly $304.56M accounting for 3.52% of the overall portfolio. To date, the estimated cost basis is nearly $20.14 for "buy" trades and estimated average "sell" price is $21.32. Greenhaven Associates first purchased BAX in 2025 Q3, initially acquiring about 6.29M shares. Since the initial investment in Baxter International Inc (BAX), Greenhaven Associates has made 3 more transactions.
When did Edgar Wachenheim III buy Baxter International Inc (BAX)?
Edgar Wachenheim III first invested in Baxter International Inc (BAX) in 2025 Q3 at the reported quarter-end price of $22.77 per share.
What's the cost basis of Greenhaven Associates's BAX stake?
The estimated cost basis for Baxter International Inc (BAX) stake is around $20.14 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $20.14
- Weighted AVG sell price:
- $21.32
Edgar Wachenheim III's historical trades in Baxter International Inc
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
3.52%
|
14,285,228
|
$21.32
|
$304,561,061
|
-0.16% (-22,460)
|
-0.01%
|
|
2026 Q1
|
3.96%
|
14,307,688
|
$16.80
|
$240,369,158
|
+33.80% (+3,614,465)
|
+1%
|
|
2025 Q4
|
3.31%
|
10,693,223
|
$19.11
|
$204,347,492
|
+70.05% (+4,404,874)
|
+1.36%
|
|
2025 Q3
|
2.18%
|
6,288,349
|
$22.77
|
$143,185,707
|
new
|
+2.18%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.